Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

Completed · Not applicable

Conditions studied: Meibomian Gland Dysfunction, Evaporative Dry Eye Disease

In brief

The purpose of this post-approval study is to demonstrate that iLux treatment offers comparable treatment effectiveness to LipiFlow for MGD treatment at 12 months post single treatment.

Key facts

Study ID

NCT03956225

Run by

Alcon Research

People needed

299

Starts

2019-06-25

Expected to finish

2020-10-24

Last updated by the study team

2021-10-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Understand and sign an Informed Consent document;
• Have Meibomian Gland Dysfunction with evaporative dry eye disease at the screening visit;
• Agree not to wear contact lenses for the duration of the study;
• Other protocol-specified inclusion criteria may apply.

You may not qualify if…

• History of eye surgery, as specified in the protocol;
• Eye infection or inflammation, as specified in the protocol;
• Eyelid abnormalities; eyelid tattoos;
• Treated with LipiFlow or iLux in either eye in the last 12 months;
• Contact lens wear within the 1 month prior to Screening;
• Other protocol-specified exclusion criteria may apply.

Where it is running

• Alcon Investigator 9083 — Long Beach, California, United States
• Alcon Investigator 9081 — Los Angeles, California, United States
• Alcon Investigator 9084 — San Diego, California, United States
• Alcon Investigator 5127 — Panama City, Florida, United States
• Alcon Investigator 4782 — Highland Park, Illinois, United States
• Alcon Investigator 6567 — Pittsburg, Kansas, United States
• Alcon Investigator 5582 — Louisville, Kentucky, United States
• Alcon Investigator 6402 — Medina, Minnesota, United States
• Alcon Investigator 1455 — Kansas City, Missouri, United States
• Alcon Investigator 3828 — Poughkeepsie, New York, United States
• Alcon Investigator 8046 — Granville, Ohio, United States
• Alcon Investigator 6313 — Powell, Ohio, United States
• Alcon Investigator 9082 — Chambersburg, Pennsylvania, United States
• Alcon Investigator 8028 — Wichita Falls, Texas, United States
• Alcon Investigator 5163 — Kirkland, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.